Ama-NSAID - Okufanele Ukwazi

Ama-NSAID aphakathi kwezidakamizwa ezivame ukwedlula zonke

Ama-NSAID (izidakamizwa ezingavumeli ukuvuvukala) ezingenwa yi-arthritis ngokuphazamisa inqubo yokuvuvukala. Ama-NSAID yiqembu elikhulu lezidakamizwa ezisetshenziswa kakhulu ukuphatha i-arthritis ngenxa yazo:

Izigaba ze-NSAID

Kunezinhlobo ezintathu zama-NSAID:

Ama-NSAID avame ukusetshenziswa ase-arthritis afaka:

Indlela ama-NSAID asebenza ngayo

Ngamazwi alula, ama-NSAID asebenza ngokuncipha ukuvuvukala. Benza lokhu ngokuvimbela i-enzyme eyinhloko yokuvuvukala okuthiwa i-cyclooxygenase, eguqula i-arachidonic acid kuma-prostaglandins nama-leukotrienes.

I-Prostaglandins ibangela ukuvuvukala kwendawo. Ngakho-ke, ngokuvimbela i-cyclooxygenase, ama-NSAID anciphisa ukuvuvukala .

I-NSAID ethile ingase isebenze kangcono kuwe kuneyodwa owazama ngaphambili - noma ingase ingasebenzi nhlobo. Lokhu kungenxa yokuthi kukhona okushiwo ngokuthi umehluko we-pharmacokinetic - inqubo lapho isidakamizwa sithathwa khona, sisatshalaliswa, senziwe ngendlela efanele futhi sichithwa.

Okuningi ku-Cyclooxygenase Enzyme

Kunezinhlobo ezimbili ze-cyclooxygenase, eyaziwa njenge-COX-1 ne-COX-2. I-COX-1 ihilelekile ekulondolozeni izicubu ezisempilo zesisu nezinso zezinso. I-COX-2 yi-enzyme ephethwe ukuvuvukala. Ngenxa yokuthi i-NSAID yendabuko ivimba kokubili i-COX-1 ne-COX-2, ingaba nemiphumela emibi engafuneki, njengokucasuka kwesisu noma ukusebenza kwezinso. Yingakho abacwaningi bethola i-NSAIDS evimba kuphela i-COX-2 kuphela. Lezi-inhibitors ze-COX-2 ezikhethiwe yiqembu elisha lama-NSAID.

Imisebenzi ye-FDA Yonke I-NSAID

Ngo-2004, umkhiqizi we-COX-2 inhibitor wokukhetha i-Vioxx ngokuzithandela wasihoxisa emakethe ngemuva kokufundwa kwezemfundo kwabonisa ukusetshenziswa kwesikhathi eside kungandisa ingozi yokuhlasela kwenhliziyo nokushaywa yisifo sohlangothi. Ukubuyekezwa okulandelwayo yi-US Food Administration and Drug Administration kwaholela ekudingisweni kuka-2005 ukuthi wonke ama-non-aspirin NSAID aphethe isixwayiso esihlobene.

Kubalulekile ukuxoxa ngalezi zingozi ezingase zibe khona nodokotela wakho. (I-aftermath ishiye kuphela i-COX-2 inhibitor emakethe - i-Celebrex.)

Ukusebenza kwama-NSAID

Okubalulekile

Awukwazi ukubikezelwa ukuthi i-NSAID izokukhonza kangcono kakhulu. Ayikho i-NSAID eyodwa eye yaboniswa ukuthi iphakeme ngaphezu kwamanye ukusizwa ubuhlungu. Uma ngabe i-NSAID ikhethiwe, umthamo kufanele ukwandiswe kuze kube yilapho ubuhlungu bukhululiwe noma kuze kube sekufinyelelwe umthamo obekezeleleke owenziwe. Impendulo yesiguli kufanele ibe yisiqondiso sokukhetha umthamo ofanele, usebenzisa umthamo ophansi kunazo zonke ukuthola ukukhululeka kobuhlungu. Hlala uxoxisana ngezinzuzo kanye nezingozi ezingenzeka ze-NSAID nodokotela wakho.

> Imithombo:

> I-Duke University Medical Center Book of Arthritis, uDavid S. Pisetsky, MD, Ph.D. 1995.

> I-New England Journal of Medicine, 324 (24): 1716-1725, 1991